{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:27:44Z","timestamp":1794580064000,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Canada\u2019s Substance Use and Addictions Program","award":["2122-HQ-000021"],"award-info":[{"award-number":["2122-HQ-000021"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["181006"],"award-info":[{"award-number":["181006"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Public Health"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The ongoing drug poisoning crisis continues to cause significant mortality, with a disproportionate number of overdose deaths occurring when individuals use drugs alone. While supervised consumption sites (SCS) have proven effective in reducing overdose fatalities, their impact is limited by geographic, social, and systemic barriers. In response, overdose response technologies have emerged to expand access to life-saving interventions beyond the reach of traditional harm reduction infrastructure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Overdose response technologies (e.g., National Overdose Response Service (NORS)) and applications (e.g., Lifeguard App, UnityPhilly) offer real-time monitoring during solitary substance use. Hotlines provide peer-operated support and activate emergency responses if a caller becomes unresponsive, while apps use timers and geolocation to trigger automatic emergency services dispatch. Despite promising early outcomes, these services operate in a fragmented policy landscape without formalized regulatory guidance or implementation best practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Preliminary data show that services like NORS have successfully prevented overdose deaths; however, published outcomes for most services remain limited. Key areas of priority for standards include the following: ensuring privacy for service, balancing data usage for quality improvement and research, building capacity to further equity of access to healthcare and harm reduction using the virtual platform, standardizing overdose response, and providing appropriate education around the efficacy of services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>To enhance the effectiveness and sustainability of overdose response technologies, a comprehensive policy or standards framework is needed. This includes guidance on data privacy, service equity, public education, capacity-building, and outcome evaluation, laying the groundwork for safer, scalable, and more accessible overdose prevention interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.17269\/s41997-026-01180-3","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:18:10Z","timestamp":1773940690000},"page":"1132-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Policy recommendations for overdose response hotlines and applications as a harm reduction tool: A commentary"],"prefix":"10.17269","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-9751","authenticated-orcid":false,"given":"William","family":"Rioux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Weleff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boogyung","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Shover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Monty","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"1180_CR1","unstructured":"Alberta substance use surveillance system\u2014SAS\u00ae Visual Analytics. (n.d.). Retrieved\u00a0 2023, from https:\/\/healthanalytics.alberta.ca\/SASVisualAnalytics\/?reportUri=%2Freports%2Freports%2F1bbb695d-14b1-4346-b66e-d401a40f53e6&sectionIndex=0&sso_guest=true&reportViewOnly=true&reportContextBar=false&sas-welcome=false"},{"issue":"6","key":"1180_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","volume":"38","author":"L Belzak","year":"2018","unstructured":"Belzak, L., & Halverson, J. (2018). Evidence synthesis - The opioid crisis in Canada: A national perspective. Health Promotion and Chronic Disease Prevention in Canada, 38(6), 224\u2013233. https:\/\/doi.org\/10.24095\/hpcdp.38.6.02","journal-title":"Health Promotion and Chronic Disease Prevention in Canada"},{"key":"1180_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104559","volume":"132","author":"H Byles","year":"2024","unstructured":"Byles, H., Sedaghat, N., Rider, N., Rioux, W., Loverock, A., Seo, B., Dhanoa, A., Orr, T., Dunnewold, N., Tjosvold, L., & Ghosh, S. (2024). Barriers to calling emergency services amongst people who use substances in the event of overdose: A scoping review. International Journal of Drug Policy, 132, Article 104559. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104559","journal-title":"International Journal of Drug Policy"},{"key":"1180_CR4","unstructured":"Canada, O. of the P. C. of. (2014). Summary of privacy laws in Canada. https:\/\/www.priv.gc.ca\/en\/privacy-topics\/privacy-laws-in-canada\/02_05_d_15\/. Accessed 7\/10\/2024."},{"key":"1180_CR5","unstructured":"Canadian Center on Substance Use and Addiction. (2020). Submission to Health Canada\u2019s Consultation to Inform Proposed New Regulations for Supervised Consumption Sites and Services. https:\/\/www.ccsa.ca\/sites\/default\/files\/2020-11\/CCSA-Submission-Proposed-Regulations-Supervised-Consumption-Sites-Services-Brief-2020-en.pdf. Accessed\u00a07\/15\/2024."},{"issue":"12","key":"1180_CR6","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/add.14747","volume":"114","author":"JP Caulkins","year":"2019","unstructured":"Caulkins, J. P., Pardo, B., & Kilmer, B. (2019). Supervised consumption sites: A nuanced assessment of the causal evidence. Addiction, 114(12), 2109\u20132115. https:\/\/doi.org\/10.1111\/add.14747","journal-title":"Addiction"},{"issue":"6","key":"1180_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.5811\/westjem.2018.8.38829","volume":"19","author":"A Gunn","year":"2018","unstructured":"Gunn, A., Smothers, Z., Schramm-Sapyta, N., Freiermuth, C., MacEachern, M., & Muzyk, A. (2018). The emergency department as an opportunity for naloxone distribution. Western Journal of Emergency Medicine, 19(6), 1036\u20131042. https:\/\/doi.org\/10.5811\/westjem.2018.8.38829","journal-title":"Western Journal of Emergency Medicine"},{"issue":"10324","key":"1180_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","volume":"399","author":"K Humphreys","year":"2022","unstructured":"Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cu\u00e9llar, M.-F., Hurd, Y. L., Juurlink, D. N., Koh, H. K., Krebs, E. E., Lembke, A., Mackey, S. C., Larrimore Ouellette, L., Suffoletto, B., & Timko, C. (2022). Responding to the opioid crisis in North America and beyond: Recommendations of the Stanford\u2013Lancet Commission. The Lancet, 399(10324), 555\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(21)02252-2","journal-title":"The Lancet"},{"issue":"3","key":"1180_CR9","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","volume":"7","author":"MA Irvine","year":"2022","unstructured":"Irvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., & Green, T. C. (2022). Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: A modelling study. The Lancet Public Health, 7(3), e210\u2013e218. https:\/\/doi.org\/10.1016\/S2468-2667(21)00304-2","journal-title":"The Lancet Public Health"},{"issue":"4","key":"1180_CR10","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/S2468-2667(21)00007-4","volume":"6","author":"C Keen","year":"2021","unstructured":"Keen, C., Kinner, S. A., Young, J. T., Snow, K., Zhao, B., Gan, W., & Slaunwhite, A. K. (2021). Periods of altered risk for non-fatal drug overdose: A self-controlled case series. The Lancet Public Health, 6(4), e249\u2013e259. https:\/\/doi.org\/10.1016\/S2468-2667(21)00007-4","journal-title":"The Lancet Public Health"},{"issue":"4","key":"1180_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/YCO.0000000000000712","volume":"34","author":"RM Krausz","year":"2021","unstructured":"Krausz, R. M., Westenberg, J. N., & Ziafat, K. (2021). The opioid overdose crisis as a global health challenge. Current Opinion in Psychiatry, 34(4), 405. https:\/\/doi.org\/10.1097\/YCO.0000000000000712","journal-title":"Current Opinion in Psychiatry"},{"issue":"3","key":"1180_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.amepre.2022.04.021","volume":"63","author":"CJ Livingston","year":"2022","unstructured":"Livingston, C. J., Berenji, M., Titus, T. M., Caplan, L. S., Freeman, R. J., Sherin, K. M., Mohammad, A., & Salisbury-Afshar, E. M. (2022). American College of Preventive Medicine: Addressing the Opioid Epidemic Through a Prevention Framework. American Journal of Preventive Medicine, 63(3), 454\u2013465. https:\/\/doi.org\/10.1016\/j.amepre.2022.04.021","journal-title":"American Journal of Preventive Medicine"},{"issue":"9775","key":"1180_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall, B. D., Milloy, M.-J., Wood, E., Montaner, J. S., & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: A retrospective population-based study. Lancet, 377(9775), 1429\u20131437. https:\/\/doi.org\/10.1016\/S0140-6736(10)62353-7","journal-title":"Lancet"},{"issue":"46","key":"1180_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1503\/cmaj.220579","volume":"194","author":"G Matskiv","year":"2022","unstructured":"Matskiv, G., Marshall, T., Krieg, O., Viste, D., & Ghosh, S. M. (2022). Virtual overdose monitoring services: A novel adjunctive harm reduction approach for addressing the overdose crisis. Canadian Medical Association Journal, 194(46), 5.","journal-title":"Canadian Medical Association Journal"},{"issue":"10","key":"1180_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamasurg.2017.2230","volume":"152","author":"HK Mell","year":"2017","unstructured":"Mell, H. K., Mumma, S. N., Hiestand, B., Carr, B. G., Holland, T., & Stopyra, J. (2017). Emergency Medical Services Response Times in Rural, Suburban, and Urban Areas. JAMA Surgery, 152(10), 983. https:\/\/doi.org\/10.1001\/jamasurg.2017.2230","journal-title":"JAMA Surgery"},{"key":"1180_CR16","unstructured":"M\u00e9tis Nation BC Launches Life-Saving Technology. (2021). MNBC. https:\/\/www.mnbc.ca\/news\/metis-nation-bc-launches-life-saving-technology. Accessed\u00a09\/11\/2024."},{"key":"1180_CR17","doi-asserted-by":"publisher","unstructured":"Michaud, L., der Meulen, E., & Guta, A. (2022). Between care and control: Examining surveillance practices in harm reduction. Contemporary Drug Problems\u00a0(1). https:\/\/doi.org\/10.1177\/00914509221128598","DOI":"10.1177\/00914509221128598"},{"issue":"1","key":"1180_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/09646639241249074","volume":"34","author":"L Michaud","year":"2025","unstructured":"Michaud, L., van der Meulen, E., Chu, S. K. H., & Butler-McPhee, J. (2025). \u201cThe Law is too Grey\u201d: Liminal legality and moral injury in encounters with drug law enforcement. Social & Legal Studies, 34(1), 110\u2013129. https:\/\/doi.org\/10.1177\/09646639241249074","journal-title":"Social & Legal Studies"},{"key":"1180_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2024.100770","author":"V Mocanu","year":"2024","unstructured":"Mocanu, V., Viste, D., Rioux, W., & Ghosh, S. M. (2024). Accessibility gaps of physical supervised consumption sites in Canada motivating the use of overdose response technology\/phone based virtual overdose response services: A retrospective cohort study. The Lancet Regional Health - Americas. https:\/\/doi.org\/10.1016\/j.lana.2024.100770","journal-title":"The Lancet Regional Health - Americas"},{"issue":"6","key":"1180_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002661","volume":"4","author":"JK Murphy","year":"2024","unstructured":"Murphy, J. K., Saker, S., Chakraborty, P. A., Chan, Y. M., Michalak, E. E., Irrarazaval, M., Withers, M., Ng, C. H., Khan, A., Greenshaw, A., O\u2019Neil, J., Nguyen, V. C., Minas, H., Ravindran, A., Paric, A., Chen, J., Wang, X., Hwang, T.-Y., Ibrahim, N., \u2026 Lam, R. W. (2024). Advancing equitable access to digital mental health in the Asia-Pacific region in the context of the COVID-19 pandemic and beyond: A modified Delphi consensus study. PLOS Global Public Health, 4(6), Article e0002661. https:\/\/doi.org\/10.1371\/journal.pgph.0002661","journal-title":"PLOS Global Public Health"},{"issue":"9","key":"1180_CR21","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2471\/BLT.18.224089","volume":"97","author":"D O\u2019Keefe","year":"2019","unstructured":"O\u2019Keefe, D., Bluthenthal, R. N., Kral, A. H., Aitken, C. K., McCormack, A., & Dietze, P. M. (2019). Measures of harm reduction service provision for people who inject drugs. Bulletin of the World Health Organization, 97(9), 605\u2013611. https:\/\/doi.org\/10.2471\/BLT.18.224089","journal-title":"Bulletin of the World Health Organization"},{"key":"1180_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103815","volume":"108","author":"M Perri","year":"2022","unstructured":"Perri, M., Schmidt, R. A., Guta, A., Kaminski, N., Rudzinski, K., & Strike, C. (2022). COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services. International Journal of Drug Policy, 108, Article 103815. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103815","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"1180_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-022-00682-w","volume":"19","author":"E Pourtaher","year":"2022","unstructured":"Pourtaher, E., Payne, E. R., Fera, N., Rowe, K., Leung, S.-Y., Stancliff, S., Hammer, M., Vinehout, J., & Dailey, M. W. (2022). Naloxone administration by law enforcement officers in New York State (2015\u20132020). Harm Reduction Journal, 19(1), Article 102. https:\/\/doi.org\/10.1186\/s12954-022-00682-w","journal-title":"Harm Reduction Journal"},{"key":"1180_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2023.2271642","author":"N Rider","year":"2023","unstructured":"Rider, N., Safi, F., Marshall, T., Jones, S., Seo, B., Viste, D., Taplay, P. E., Rioux, W., & Ghosh, S. M. (2023). Investigating uses of peer-operated Virtual Overdose Monitoring Services (VOMS) beyond overdose response: A qualitative study. The American Journal of Drug and Alcohol Abuse. https:\/\/doi.org\/10.1080\/00952990.2023.2271642","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"1180_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104121","volume":"119","author":"W Rioux","year":"2023","unstructured":"Rioux, W., Marshall, T., & Ghosh, S. M. (2023). Virtual overdose monitoring services and overdose prevention technologies: Opportunities, limitations, and future directions. International Journal of Drug Policy, 119, Article 104121. https:\/\/doi.org\/10.1016\/j.drugpo.2023.104121","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"1180_CR26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/dar.14055","volume":"44","author":"W Rioux","year":"2025","unstructured":"Rioux, W., Viste, D., Sedaghat, N., Rider, N., Tek, J. T. W., Perri, M., Schwartz, D. G., Ritchie, K., Carr\u00e0, G., Carreiro, S., Kreig, O., Marcu, G., Arthur, J., Cogdell, J., Brown, M., Marshall, T., & Ghosh, S. M. (2025). Defining terminology and outcome measures for evaluating overdose response technology: An international Delphi study. Drug and Alcohol Review, 44(5), 1430\u20131443. https:\/\/doi.org\/10.1111\/dar.14055","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"1180_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00792-z","volume":"20","author":"F Safi","year":"2023","unstructured":"Safi, F., Rioux, W., Rider, N., Fornssler, B., Jones, S., & Ghosh, S. M. (2023). Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: A qualitative study. Harm Reduction Journal, 20(1), Article 64. https:\/\/doi.org\/10.1186\/s12954-023-00792-z","journal-title":"Harm Reduction Journal"},{"issue":"6","key":"1180_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.17269\/s41997-023-00825-x","volume":"114","author":"G Salvalaggio","year":"2023","unstructured":"Salvalaggio, G., Brooks, H., Caine, V., Gagnon, M., Godley, J., Houston, S., Kennedy, M. C., Kosteniuk, B., Livingston, J., Saah, R., Speed, K., Urbanoski, K., Werb, D., & Hyshka, E. (2023). Flawed reports can harm: The case of supervised consumption services in Alberta. Canadian Journal of Public Health, 114(6), 928\u2013933. https:\/\/doi.org\/10.17269\/s41997-023-00825-x","journal-title":"Canadian Journal of Public Health"},{"key":"1180_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100474","volume":"25","author":"DG Schwartz","year":"2020","unstructured":"Schwartz, D. G., Ataiants, J., Roth, A., Marcu, G., Yahav, I., Cocchiaro, B., Khalemsky, M., & Lankenau, S. (2020). Layperson reversal of opioid overdose supported by smartphone alert: A prospective observational cohort study. EClinicalMedicine, 25, Article 100474. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100474","journal-title":"EClinicalMedicine"},{"issue":"1","key":"1180_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00946-7","volume":"21","author":"B Seo","year":"2024","unstructured":"Seo, B., Rider, N., Rioux, W., Teare, A., Jones, S., Taplay, P., & Monty Ghosh, S. (2024). Understanding the barriers and facilitators to implementing and sustaining mobile overdose response services from the perspective of Canadian key interest groups: A qualitative study. Harm Reduction Journal, 21(1), Article 28. https:\/\/doi.org\/10.1186\/s12954-024-00946-7","journal-title":"Harm Reduction Journal"},{"issue":"9","key":"1180_CR31","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1080\/10826084.2022.2083173","volume":"57","author":"E van der Meulen","year":"2022","unstructured":"van der Meulen, E., & Chu, S. K. H. (2022). \u201cThe law doesn\u2019t protect me\u201d: Examining the effectiveness of Good Samaritan Drug Overdose Legislation. Substance Use & Misuse, 57(9), 1392\u20131399. https:\/\/doi.org\/10.1080\/10826084.2022.2083173","journal-title":"Substance Use & Misuse"},{"key":"1180_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103039","volume":"88","author":"E van der Meulen","year":"2021","unstructured":"van der Meulen, E., Chu, S. K. H., & Butler-McPhee, J. (2021). \u201cThat\u2019s why people don\u2019t call 911\u201d: Ending routine police attendance at drug overdoses. International Journal of Drug Policy, 88, Article 103039. https:\/\/doi.org\/10.1016\/j.drugpo.2020.103039","journal-title":"International Journal of Drug Policy"},{"key":"1180_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16751-z","author":"D Viste","year":"2023","unstructured":"Viste, D., Rioux, W., Cristall, N., Orr, T., Taplay, P., Morris-Miller, L., & Ghosh, S. M. (2023). Association of drug overdoses and user characteristics of Canada\u2019s national mobile\/virtual overdose response hotline: The National Overdose Response Service (NORS). BMC Public Health. https:\/\/doi.org\/10.1186\/s12889-023-16751-z","journal-title":"BMC Public Health"}],"container-title":["Canadian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-026-01180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.17269\/s41997-026-01180-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.17269\/s41997-026-01180-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:57:56Z","timestamp":1794578276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.17269\/s41997-026-01180-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1180"],"URL":"https:\/\/doi.org\/10.17269\/s41997-026-01180-3","relation":{},"ISSN":["0008-4263","1920-7476"],"issn-type":[{"value":"0008-4263","type":"print"},{"value":"1920-7476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ghosh co-founded NORS and belongs to the Canadian Society of Addiction Medicine and has no personal financial conflicts of interest to disclose. The results of this work may be used to apply for funding for NORS or to make operational changes to NORS. The rest of the authors are unaffiliated with any other overdose response technology or NORS in particular and have no competing interests to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}